SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-17-002184
Filing Date
2017-04-21
Accepted
2017-04-21 09:07:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT admp-s3_041717.htm S-3 57262
2 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN, LAW CORPORATION ex5-1.htm EX-5.1 7421
3 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-1.htm EX-23.1 3302
4 CONSENT OF HUDSON, CISNE & CO. LLP. ex23-2.htm EX-23.2 3414
  Complete submission text file 0001387131-17-002184.txt   72493
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217400 | Film No.: 17774326
SIC: 2834 Pharmaceutical Preparations